Drug Shortage Report for JAMP-NYSTATIN ORAL SUSPENSION USP
Report ID | 211795 |
Drug Identification Number | 02433443 |
Brand name | JAMP-NYSTATIN ORAL SUSPENSION USP |
Common or Proper name | Nystatin Oral Suspension USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 100 |
ATC code | A07AA |
ATC description | INTESTINALANTIINFECTIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-11-27 |
Estimated end date | 2025-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-01-23 |
Company comments | Under allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2025-01-23 | French | Compare |
v21 | 2025-01-23 | English | Compare |
v20 | 2025-01-04 | French | Compare |
v19 | 2025-01-04 | English | Compare |
v18 | 2024-12-03 | French | Compare |
v17 | 2024-12-03 | English | Compare |
v16 | 2024-11-01 | French | Compare |
v15 | 2024-11-01 | English | Compare |
v14 | 2024-11-01 | French | Compare |
v13 | 2024-11-01 | English | Compare |
v12 | 2024-09-04 | French | Compare |
v11 | 2024-09-04 | English | Compare |
v10 | 2024-07-03 | French | Compare |
v9 | 2024-07-03 | English | Compare |
v8 | 2024-03-11 | French | Compare |
v7 | 2024-03-11 | English | Compare |
v6 | 2024-03-04 | French | Compare |
v5 | 2024-03-04 | English | Compare |
v4 | 2024-02-19 | French | Compare |
v3 | 2024-02-19 | English | Compare |